Through this multilayered approach, we aimed to delineate the spatial, cellular, and functional characteristics of PLXNA3, and to assess its potential as a prognostic biomarker and therapeutic target in CRC. The gene discussed is PLXNA3; the disease is colorectal carcinoma.